Consensus Claritev Corporation

Stocks

CTEV

US62548M2098

Business Support Services

Real-time Estimate Cboe BZX 10:31:13 18/09/2026 pm IST			5-day change	1st Jan Change
31.68 ^USD	-0.17%		-12.81%	-26.62%

10/09	TPG explores $5 billion sale of healthcare software company Lyric, sources say	RE
17/08	Marpai, Inc. Expands Relationship with Claritev Corporation to Help Reduce Healthcare Costs for Employer Clients	CI

Evolution of the Average Target: Claritev Corporation

Evolution of the Target Price: Claritev Corporation

Changes in Analyst Recommendations: Claritev Corporation

f2e1336888c1914897fffabde8.mQGr3TcFkkPwddF2nqF-RO7nlTQTZ_PdwfgvDBC5d0w.71Sbh11RwnGkIqMur-U5doaF9Ax9LYKxuYhKXkqJJwTwZtG4WV2iBagypg~0ccc778d276beb4ab19ff95e8679dc52

Analysts' recommendations: Claritev Corporation

29/05	Canaccord Genuity Initiates Claritev at Buy With $32 Price Target	MT
12/01	Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target	MT
09/01	Wells Fargo Initiates Claritev Corp at Equalweight With $33 Price Target	MT
22/25/22	Claritev Shares Rise After Upgrade From Citigroup	MT
21/25/21	Citigroup Upgrades Claritev to Buy From Neutral, $55 Price Target	MT
30/25/30	Claritev Shares Rise After Upgrade From Piper Sandler	MT
29/25/29	Piper Sandler Upgrades Claritev to Overweight From Neutral, Adjusts Price Target to $44 From $19	MT
26/24/26	Piper Sandler Initiates MultiPlan at Neutral With $2 Price Target	MT
08/23/08	Citigroup Adjusts Price Target on MultiPlan to $1.25 From $2, Keeps Neutral Rating	MT
18/23/18	Barclays Adjusts Price Target on MultiPlan to $1 From $3, Maintains Equal-Weight Rating	MT
13/22/13	Citigroup Downgrades MultiPlan to Neutral From Buy, Cuts Price Target to $2 From $3	MT
16/22/16	Goldman Sachs Adjusts Price Target on MultiPlan to $2.05 From $5.50, Maintains Neutral Rating	MT
09/22/09	Citigroup Adjusts Price Target on MultiPlan to $3 From $6, Maintains Buy Rating	MT
12/22/12	Goldman Sachs Starts MultiPlan at Neutral With $6.50 Price Target	MT
20/21/20	Citigroup Adjusts MultiPlan's Price Target to $7 from $9, Keeps Buy Rating	MT
11/21/11	Barclays Adjusts MultiPlan's Price Target to $6 From $7, Keeps Equal-Weight Rating	MT
20/21/20	MultiPlan : Tigress Research Initiates Coverage of MultiPlan with Buy Rating, $9 Price Target	MT
07/21/07	MultiPlan : B. Riley Starts MultiPlan at Buy with $10 Price Target; Expects Material Revenue, Earnings Growth Ahead	MT
19/21/19	MultiPlan : Barclays Starts MultiPlan at Equalweight with $7 Price Target	MT
16/20/16	MultiPlan : Citigroup Starts MultiPlan at Buy With $10 Price Target	MT

More recommendations

Data Processing Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Objective/dr gap
CLARITEV CORPORATION		+44.45%
NEBIUS GROUP		+33.36%
MOBILITY GLOBAL, INC.		+22.69%
KEHUA DATA CO., LTD.		+41.23%
SHANGHAI @HUB CO.,LTD.		+22.2%
JMDC INC.		+22.79%
SDIC INTELLIGENCE INFORMATION TECHNOLOGY CO., LTD.	-	+60.73%
Average		+35.35%
Weighted average by Cap.		+32.75%